Library
Log In
Log in with your UoM account
Problems logging in with your UoM account?
or
Guest login
Email address
Password
No UoM account? Click here to register a guest account.
Have you forgotten your guest credentials?
Library
FAQs
Communities & Collections
Browse Repository
Statistics
My Lists
search
Search
Log In
Log in with your UoM account
Problems logging in with your UoM account?
or
Guest login
Email address
Password
No UoM account? Click here to register a guest account.
Have you forgotten your guest credentials?
Home
Minerva Access
Medicine, Dentistry & Health Sciences
Sir Peter MacCallum Department of Oncology
Sir Peter MacCallum Department of Oncology - Research Publications
ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901)